'Biosimilar' drugs poised to penetrate market

Heidi Ledford

Nature, 2010, vol. 468, issue 7320, 18-19

Abstract: Draft regulations will pave the way for copycat antibodies and other large molecules.

Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/468018a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:468:y:2010:i:7320:d:10.1038_468018a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/468018a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().